• Policy & Insight

Opinion: 'Why we need earlier diagnosis of cancer more than ever before'

Professor Georgios Lyratzopoulos leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group and CanTest at University College London. Professor Georgios Lyratzopoulos leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group and CanTest at University College London.

3 February 2021

• For Supporters

“We wanted to do everything we could to support them”: Nick and Annette Razey give £1m to back Cancer Grand Challenges team

Their donation, which rises to £1.25m with Gift Aid, will help scientists uncover secrets of the gut microbiome, which could lead to new bowel cancer treatments Their donation, which rises to £1.25m with Gift Aid, will help scientists uncover secrets of the gut microbiome, which could lead to new bowel cancer treatments

3 February 2021

• Health & Medicine

Cancer services during COVID-19: 40,000 fewer people starting treatment

There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services. There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.

2 February 2021

• Health & Medicine

FIT sees pre-pandemic bowel screening uptake increase in Scotland

Temporary disruption to the screening programme over the last year must not become a permanent setback in efforts to save more lives from cancer. Temporary disruption to the screening programme over the last year must not become a permanent setback in efforts to save more lives from cancer.

2 February 2021

• Health & Medicine

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab. People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab.

30 January 2021

• Health & Medicine
• Policy & Insight

Opinion: 'Beating cancer means beating it for everyone'

We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell. We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell.

29 January 2021

• Charity News

Cancer Research UK launches its new equality, diversity and inclusion strategy

Cancer Research UK has today launched its first charity-wide Equality, Diversity and Inclusion strategy, outlining the charity’s commitments to improve progress Cancer Research UK has today launched its first charity-wide Equality, Diversity and Inclusion strategy, outlining the charity’s commitments to improve progress

29 January 2021

• For Researchers

2021: A bright future for cancer research

Despite a difficult 2020, there is a lot to be excited about for cancer research in 2021. Three experts tell us how progress is changing the research landscape. Despite a difficult 2020, there is a lot to be excited about for cancer research in 2021. Three experts tell us how progress is changing the research landscape.

28 January 2021

• Health & Medicine

Transforming optimism: finding new ways to treat rare cancers

We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma. We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.

27 January 2021

• Health & Medicine
• Science & Technology

Genetic changes in tumours may predict who will respond to immunotherapy

Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments.  Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments. 

27 January 2021

• Charity News

Cancer Research UK appoints new executive director of Policy, Information and Communications

The world’s leading cancer charity, Cancer Research UK, has appointed Ian Walker as its executive director of Policy, Information and Communications. The world’s leading cancer charity, Cancer Research UK, has appointed Ian Walker as its executive director of Policy, Information and Communications.

27 January 2021

• Health & Medicine

NHS COVID-19 vaccination centre opens at London’s Francis Crick Institute

The Francis Crick Institute – of which Cancer Research UK is a major funder – has partnered with UCLH to establish a COVID-19 vaccination centre. The Francis Crick Institute – of which Cancer Research UK is a major funder – has partnered with UCLH to establish a COVID-19 vaccination centre.

22 January 2021